Versant Side Fund IV, L.P.
- SEC CIK
- 0001456591
No open-market purchases or sales filed in the past year.
Current role at each company
- TPST Tempest Therapeutics, Inc.10% Owneras of Aug 12, 2024
- CTNM Contineum Therapeutics, Inc.10% Owneras of Apr 11, 2024
- OYST Oyster Point Pharma, Inc.10% Owneras of Jan 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Versant Side Fund IV, L.P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TPST Tempest Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 (view filing)8:33 PM ET | Aug 8-12 | 4 days | Versant Ventures IV, LLC and 8 others10% Owner | SSale | −788.0K | $1.23 | −$967.0K | −79.0%209.9K after | 2 lots |
OYST Oyster Point Pharma, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2021 (view filing)4:38 PM ET | Oct 18 | 2 days | Versant Ventures IV, LLC and 8 others10% Owner | SSale | −550.0K | $14.84 | −$8.16M | −99.1%4.99K after | 4 lots |